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Auditory neuropathy spectrum disorder (ANSD) is characterized by impairment of the auditory 
nerve associated with preservation of outer hair cell function.
Objective: To establish the prevalence of ANSD in subjects with sensorineural hearing loss (SNHL).
Method: This retrospective study was carried out between 2010 and 2012 and included the charts 
of 2,292 individuals with SNHL. Data from otolaryngological and audiological examinations based 
on pure-tone and speech audiometry, impedance tests, otoacoustic emissions (OAEs), and brainstem 
auditory evoked potentials (BAEPs) were collected. Inclusion criteria: presence of OAEs and/or 
cochlear microphonic (CM); absent or altered BAEPs, and normal MRI scans of the brain.
Results: Twenty-seven (1.2%) of the 2,292 subjects with SNHL had ANSD (37% males; 63% females). 
Mild SNHL was seen in 29.6% of the individuals with ANSD; 55.5% had moderate SNHL; 7.4% had 
severe SNHL; and 7.5% had profound SNHL. In terms of age, 14.8% were aged between zero and 
20 years, 44.1% were 41 to 60 years old, and 7.4% were above the age of 60.
Conclusion: ANSD was seen in 1.2% of the individuals with SNHL included in this study.
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INTRODUCTION
The term auditory neuropathy has been used to 
describe diseases affecting children and adults characte-
rized by normal outer hair cell function and anomalous 
or absent auditory nerve function; it has been described 
as a set of auditory disorders that combine otoacoustic 
emissions (OAEs) and/or cochlear microphonics (CM) with 
absent or desynchronous waves generated in brainstem 
auditory evoked potentials (BAEPs). The term auditory 
neuropathy was used for the first time in a study carried 
out in 1996 to categorize a group of subjects with hearing 
symptoms and normal cochlear function associated with 
cochlear nerve dysfunction1.
The term auditory neuropathy spectrum was pro-
duced through international consensus during the Guide-
lines Development Conference on the Identification and 
Management of Infants with Auditory Neuropathy, held 
in June of 20082. The change in nomenclature was due 
to a study carried out in 2002 in which it was revealed 
that approximately half the children with auditory neu-
ropathy had the same speech detection skills as children 
with sensorineural hearing loss, in addition to auditory 
brainstem responses, while the other half had unsatis-
factory results in speech detection tests and no auditory 
brainstem responses. It was then realized that the term 
auditory neuropathy describes an array of disorders that 
may range from auditory dyssynchrony to auditory nerve 
neuropathy3.
Individuals with auditory neuropathy spectrum 
disorder (ANSD) may present mild to severe, unilateral 
or bilateral hearing loss associated with disproportional 
impairment of speech discrimination in relation to hearing 
loss4. BAEP testing also shows widely variable audiologi-
cal results, from severely altered wave morphology to no 
wave formation, thus reflecting the multifaceted and hete-
rogeneous nature of the pathophysiology of this auditory 
disorder5. Subjects with ANSD can often hear, but fail to 
discriminate words due to the loss of neural synchrony 
between the fibers of the vestibulocochlear nerve, thus 
severely impairing temporal auditory processing and 
speech discrimination6.
The published estimated prevalence rates of ANSD7 
range from 0.23%8 to 15%9 in individuals with hearing loss. 
However, the estimated prevalence of ANSD in a study 
with patients at risk for hearing loss was 1.3%10, while a 
study with children at risk of hearing loss found a preva-
lence rate of ANSD of 0.94%11. Another study with children 
with hearing loss revealed prevalence rates ranging from 
5.1% to 15%12. A study on sensorineural hearing loss found 
ANSD in 1.6%13 of the enrolled patients. A study with 
neonates screened for BAEPs found ANSD in 2.96%14 of the 
subjects. ANSD patients often require specific approaches 
to address their auditory, communication, and language 
impairments, which differ from the therapies proposed to 
patients with peripheral hearing loss11.
The site of injury in ANSD patients has not been 
clearly defined. Investigated sites include the inner hair 
cells, the synapses between inner hair cells and the audi-
tory nerve, dendrites or neural axons, afferent and efferent 
activity of the auditory nerve, spiral ganglion neurons, and 
neurotransmitter biochemical anomalies9,15,16.
This study aimed to identify the prevalence of ANSD 
in a group of individuals with sensorineural hearing loss 
seen at an auditory health care center.
METHOD
This cross-sectional historical cohort study was 
approved by the Research Ethics Committee of the insti-
tution (permit #190.328).
The study included subjects diagnosed with sen-
sorineural hearing loss (SNHL) seen in an audiological 
care center from 2010 to 2012. The enrollment criteria 
included:
•	 SNHL;
•	 Ear endoscopic examination characterizing 
normal middle ear function;
•	 Transient otoacoustic emissions and/or cochlear 
microphonics in brainstem auditory evoked 
potential testing;
•	 Absent acoustic reflex;
•	 Absence of waves on BAEP testing or waves 
with severely altered morphology;
•	 Brain MRI scans ruling out retrocochlear dise-
ases that could affect BAEP responses; MRI 
scans were made in other centers, therefore 
the reports were used to exclude patients only.
Exclusion criteria:
•	 Individuals with mixed or conductive hearing 
loss according to pure-tone and speech audio-
metry;
•	 Individuals not willing to cooperate during tests;
•	 Subjects with retrocochlear disease seen on 
MRI scans.
A total of 2,292 individuals diagnosed with senso-
rineural hearing loss with ages ranging from zero to 95 
years were assessed. They underwent thorough assess-
ment, comprised by ENT examination to find the status 
of the ear canal and the tympanic membrane through 
conventional otoscopy; basic audiological examination 
including impedance tests, pure-tone audiometry, and 
speech audiometry. The following devices were used: 
impedance testing device AT-235 (Interacoustics), 
audiometer AC-33 (Interacoustics).
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OAEs were recorded with a Madsen Capela (Oto-
metrics) device. Distortion product otoacoustic emissions 
were recorded at 700 Hz and 8000 Hz, and intensity 
of stimuli was kept fixed on L1 at 65 dBNPS and L2 at 
55 dBNPS along with a ratio between frequencies of 1.22 
(F2/F1 = 1.22). Response was interpreted as present in the 
frequencies in which the signal to noise ratio was 6 dB, 
reproducibility was equal to or greater than 70%, and 
stability was equal to or greater than 75%.
BAEPs and CM were assessed using device Chartr 
EP (Otometrics) with patients wearing in-ear earphones. 
Monaural clicks set initially at 100 dBNA were used at 
least twice in BAEP testing to confirm the presence of 
overlapping waves. Stimulus frequencies ranged from 
250 Hz to 8000 Hz each lasting 100 microseconds; 
condensation and rarefaction clicks were presented 
27.7 times per second with a 12 ms window. Absence 
of wave formation on BAEP testing with stimuli up to 
100 dBNA and severe wave morphology alterations in 
BAEP consisting of low amplitude wave V at 100 dBNA 
were characterized. CM was recorded during BAEP tes-
ting using clicks with inverted polarity (condensation 
and rarefaction). When CM was present at 100 dBNA, 
intensities in decreasing steps of 20 dBNA were tested 
to the minimum level at which the potential could be 
verified. The absolute latencies for waves I, III, and V 
were measured and found to have varied significan-
tly due to alterations in morphology, amplitude, and 
latency, but such measurements were not part of the 
goals of the study. BAEP and OAE tests were conducted 
without the use of sedatives. The classification proposed 
by Goodman17 was used to categorize SNHL.
RESULTS
Twenty-seven (1.2%) of the 2,292 subjects included 
in the study diagnosed with SNHL (Graph 1) met the cri-
teria for ANSD. They had absent or severely anomalous 
waves on BAEP and OAE tests and/or normal CM, in 
addition to normal brain MRI scans. All 27 individuals had 
binaural ANSD.
Ten (37%) of the 27 subjects were males and 17 
(63%) were females (Graph 2).
When age distribution was considered, four (14.8%) 
subjects were aged between zero and 20 years; nine 
(33.4%) were aged between 21 and 40; 12 (44.4%) were 
aged between 41 and 60; and two (7.4%) were above 60 
(Graph 3).
Pure-tone and speech audiometry indicated that 
eight (29.6%) subjects had mild SNHL; 15 (55.5%) had 
moderate SNHL; two (7.4%) had severe SNHL; and two 
(7.5%) had profound SNHL (Graph 4). Impedance tests 
revealed that none of the individuals had stapedial 
reflexes.
Graph 1. Percent distribution of subjects with auditory neuropathy 
spectrum disorder (ANSD).
Graph 2. Gender percent distribution of subjects with auditory neuro-
pathy spectrum disorder (ANSD).
Graph 3. Age percent distribution of subjects with auditory neuropathy 
spectrum disorder (ANSD).
Graph 4. Percent distribution of subjects with auditory neuropathy 
spectrum disorder (ANSD) according to degree of hearing loss.
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The 27 subjects diagnosed with ANSD were fitted 
with hearing aids. Functional gain was observed in three 
(11.1%) individuals, and 24 (88.9%) had no functional 
gain (Graph 5).
ANSD progression and the damage to hair cells cau-
sed by the cochlear damage produced by the amplification 
provided by hearing aids in subjects with SNHL lead to 
the disappearance of OAEs and hamper the diagnosis of 
ANSD. Thus, cochlear microphonics become a relevant 
part of the tests used to diagnose patients with ANSD24.
In our study, all subjects diagnosed with ANSD 
met the criteria for preserved cochlear function associated 
with altered or absent auditory nerve function according 
to OAE and BAEP testing, respectively. Test results were 
consistent with the findings described in the literature in 
regards to gender distribution, age range, and degree of 
hearing loss25-27. Only three (11.6%) of the 27 individuals 
with ANSD had some functional gain after they were fitted 
with hearing aids, revealing the unsatisfactory outcome of 
this intervention.
Cochlear implants may improve the waves on 
BAEP testing and the speech of subjects with ANSD28, 
in addition to effectively improving the hearing of more 
than 90% of the affected individuals by compensating the 
neural synchrony alteration seen in ANSD and improving 
speech recognition29,30.
ANSD is not an extremely rare auditory condition. 
The accurate diagnosis of this disease requires, in addi-
tion to audiological assessment, objective OAE, CM, and 
BAEP tests, as the presence of CM or OAEs associated 
with BAEP wave absence or dyssynchrony is a significant 
diagnostic criterion.
ANSD is a challenging condition, as many factors 
concerned with its pathogenesis and etiology are yet 
unclear. More studies are required to provide much needed 
clarification on ANSD.
CONCLUSION
The prevalence of auditory neuropathy spectrum 
disorder in this study in subjects with sensorineural hearing 
loss was 1.2%, as also reported in the literature.
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